Seasonal Influenza Vaccines Market Size by Vaccine type, Virus, Distribution, Age Group, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029

7.2%
CAGR (2022-2029)
7.06 USD Bn.
Market Size
325
Report Pages
158
Market Tables

Overview

Seasonal Influenza Vaccines Market is expected to reach US$ 12.31 Bn. at a CAGR of 7.2% during the forecast period 2029.

Seasonal influenza is a respiratory tract infection disease that is caused by seasonal influenza viruses. It is a infectious and can be transmitted through direct contact with the patient or some form of indirect contact. It is mainly caused by seasonal influenza viruses such as influenza A, influenza B, and influenza C virus. The symptoms of seasonal influenza include headache, sudden onset of fever, joint pain and sore throat. The most effective way to cure seasonal influenza is vaccination.

Seasonal Influenza Vaccines MarketTo know about the Research Methodology :- Request Free Sample Report

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Seasonal Influenza Vaccines Market Drivers and Restrains

Rates of infection from seasonal influenza are highest among children and adults ages 65 years and older. Increase in the prevalence of influenza globally, growing awareness about influenza, improved health care infrastructure, seasonal outbreak of pandemics, increased research and development spending, technological advancements, increased investment by major players for the development of vaccines, rich product pipeline, an rise in government initiatives are the major drivers of the seasonal influenza vaccine market. Additionally, from the 2011 to 2021–19 seasons, the annual influenza interrelated disease burden has varied from 9 to 49 million illnesses and xx thousand deaths per year. According to the Center for Diseases Control and Prevention (CDC), it has been detected that seasonal influenza viruses constantly change, which further leads to modifications in influenza vaccines to combat season-specific viral strains. Consequently, all these factors together are projected to over remunerative opportunities to the influenza vaccine market players to develop new vaccines every year. However, a rigorous regulatory framework acts as a major restraint of the global market. Manufacturers in the Seasonal Influenza Vaccines are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

Seasonal Influenza Vaccines Market Segmentation Analysis

The seasonal influenza vaccine market can be segmented into vaccine, virus, age group, distribution channel, and region. In terms of the vaccine, the market can be classified into quadrivalent, trivalent, and high-dose. The quadrivalent segment dominated the market in 2021 and the trend is projected to continue during the forecast period. Expansion of the segment is attributed to the fact that quadrivalent vaccines are suitable for the every age group and quadrivalent Vaccine containing four strains of influenza virus rather than trivalent have three strains. In terms of virus, the seasonal influenza vaccine market can be classified into type A (H1N1), type A (H3N2), and type B. The type A (H1N1) segment led the market in 2021 and is expected to continue its dominance during the forecast period. This is because of the fact that only type A viruses can cause an epidemic. On the basis of age group, the market can be divided into pediatrics and adults. The pediatrics segment dominated the market in 2021 as a result of the high prevalence and incidence rate of influenza among children. The segment is likely to maintain its market share during the forecast period. Based on the distribution channel, the seasonal influenza vaccine market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominated the market, because of a high preference for this channel of distribution. The segment is projected to maintain its leadership position from 2022 to 2029.

Seasonal Influenza Vaccines Market Regional Analysis

On the basis of region Seasonal Influenza Vaccines market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, the North America had the largest market share in 2021 and is projected to lead the market during the forecast period, owing to increase in prevalence of influenza in the region, increase in government focus on immunization programs, emergence of new vaccines, and advancements in vaccine administration. However, the Latin America is projected to emerge as a lucrative market for seasonal influenza vaccines, by reason of improvement in healthcare facilities, upsurge in disposable income, and rapid economic development.

The objective of the report is to present comprehensive analysis of Seasonal Influenza Vaccines Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Seasonal Influenza Vaccines Market dynamics, structure by analyzing the market segments, and project the Seasonal Influenza Vaccines Market size. Clear representation of competitive analysis of key players by Seasonal Influenza Vaccines Type, price, financial position, product portfolio, growth strategies, and regional presence in the Seasonal Influenza Vaccines Market make the report investor’s guide.

Scope of the Seasonal Influenza Vaccines Market: Inquire before buying

Global Seasonal Influenza Vaccines Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 7.06 Bn.
Forecast Period 2022 to 2029 CAGR: 7.2% Market Size in 2029: US $ 12.31 Bn.
Segments Covered: by Vaccine type • Quadrivalent
• Trivalent
• High-dose
by Virus • Type A (H1N1)
• Type A (H3N2)
• Type B
by Distribution • Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
by Age Group • Pediatric
• Adult

Seasonal Influenza Vaccines Market, by Region

• Asia Pacific
• North America
• Europe
• Latin America
• Middle East Africa

Seasonal Influenza Vaccines Market, Major Players

• laxoSmithKline
• Novartis
• CSL
• MedImmune
• Sanofi-Pasteur
• Solvay
• Sinovac Biotech
• Hualun Biologicals.
• Pernix Therapeutics
• Pfizer Inc
• Purdue Pharma L.P.
• Sanofi Pasteur
• SkyePharma
• GlaxoSmithKline Plc.
• AstraZenca
• Abbott Laboratories
• Seqirus
• Mitsubishi Tanabe Pharma
• Serum Institute of India Pvt. Ltd
• Mylan NV

Frequently Asked Questions:

1. Which region has the largest share in Global Seasonal Influenza Vaccines Market?
Ans: North America region holds the highest share in 2021.

2. What is the growth rate of Global Seasonal Influenza Vaccines Market?
Ans: The Global Seasonal Influenza Vaccines Market is growing at a CAGR of 7.2% during forecasting period 2022-2029.

3. What is scope of the Global Seasonal Influenza Vaccines market report?
Ans: Global Seasonal Influenza Vaccines Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Seasonal Influenza Vaccines market?
Ans: The important key players in the Global Seasonal Influenza Vaccines Market are – laxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech, Hualun Biologicals., Pernix Therapeutics, Pfizer Inc, Purdue Pharma L.P., Sanofi Pasteur, SkyePharma, GlaxoSmithKline Plc., AstraZenca, Abbott Laboratories, Seqirus, Mitsubishi Tanabe Pharma, Serum Institute of India Pvt. Ltd, and Mylan NV

5. What is the study period of this market?
Ans: The Global Seasonal Influenza Vaccines Market is studied from 2021 to 2029.

Table of Contents

Seasonal Influenza Vaccines Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Seasonal Influenza Vaccines Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Seasonal Influenza Vaccines Market Analysis and Forecast 6.1. Global Seasonal Influenza Vaccines Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Seasonal Influenza Vaccines Market Analysis and Forecast, By Vaccine type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 7.4. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, By Vaccine type 7.5. Global Seasonal Influenza Vaccines Market Analysis, By Vaccine type 7.6. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, By Vaccine type 8. Global Seasonal Influenza Vaccines Market Analysis and Forecast, By Virus 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 8.4. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, By Virus 8.5. Global Seasonal Influenza Vaccines Market Analysis, By Virus 8.6. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, By Virus 9. Global Seasonal Influenza Vaccines Market Analysis and Forecast, By Distribution 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 9.4. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, By Distribution 9.5. Global Seasonal Influenza Vaccines Market Analysis, By Distribution 9.6. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, By Distribution 10. Global Seasonal Influenza Vaccines Market Analysis and Forecast, By Age Group 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 10.4. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, By Age Group 10.5. Global Seasonal Influenza Vaccines Market Analysis, By Age Group 10.6. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, By Age Group 11. Global Seasonal Influenza Vaccines Market Analysis and Forecast, By Distribution Channel 11.1. Introduction and Definition 11.2. Key Findings 11.3. Global Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution Channel 11.4. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, By Distribution Channel 11.5. Global Seasonal Influenza Vaccines Market Analysis, By Distribution Channel 11.6. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, By Distribution Channel 12. Global Seasonal Influenza Vaccines Market Analysis, by Region 12.1. Global Seasonal Influenza Vaccines Market Value Share Analysis, by Region 12.2. Global Seasonal Influenza Vaccines Market Size (US$ Bn) Forecast, by Region 12.3. Global Seasonal Influenza Vaccines Market Attractiveness Analysis, by Region 13. North America Seasonal Influenza Vaccines Market Analysis 13.1. Key Findings 13.2. North America Seasonal Influenza Vaccines Market Overview 13.3. North America Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 13.4. North America Seasonal Influenza Vaccines Market Forecast, By Vaccine type 13.4.1. Quadrivalent 13.4.2. Trivalent 13.4.3. High-dose 13.5. North America Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 13.6. North America Seasonal Influenza Vaccines Market Forecast, By Virus 13.6.1. Type A (H1N1) 13.6.2. Type A (H3N2) 13.6.3. Type B 13.7. North America Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 13.8. North America Seasonal Influenza Vaccines Market Forecast, By Distribution 13.8.1. Hospital Pharmacies 13.8.2. Retail Pharmacies 13.8.3. Online Pharmacies 13.9. North America Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 13.10. North America Seasonal Influenza Vaccines Market Forecast, By Age Group 13.10.1. Pediatric 13.10.2. Adult 13.11. North America Seasonal Influenza Vaccines Market Value Share Analysis, by Country 13.12. North America Seasonal Influenza Vaccines Market Forecast, by Country 13.12.1. U.S. 13.12.2. Canada 13.13. North America Seasonal Influenza Vaccines Market Analysis, by Country 13.14. U.S. Seasonal Influenza Vaccines Market Forecast, By Vaccine type 13.14.1. Quadrivalent 13.14.2. Trivalent 13.14.3. High-dose 13.15. U.S. Seasonal Influenza Vaccines Market Forecast, By Virus 13.15.1. Type A (H1N1) 13.15.2. Type A (H3N2) 13.15.3. Type B 13.16. U.S. Seasonal Influenza Vaccines Market Forecast, By Distribution 13.16.1. Hospital Pharmacies 13.16.2. Retail Pharmacies 13.16.3. Online Pharmacies 13.17. U.S. Seasonal Influenza Vaccines Market Forecast, By Age Group 13.17.1. Pediatric 13.17.2. Adult 13.18. Canada Seasonal Influenza Vaccines Market Forecast, By Vaccine type 13.18.1. Quadrivalent 13.18.2. Trivalent 13.18.3. High-dose 13.19. Canada Seasonal Influenza Vaccines Market Forecast, By Virus 13.19.1. Type A (H1N1) 13.19.2. Type A (H3N2) 13.19.3. Type B 13.20. Canada Seasonal Influenza Vaccines Market Forecast, By Distribution 13.20.1. Hospital Pharmacies 13.20.2. Retail Pharmacies 13.20.3. Online Pharmacies 13.21. Canada Seasonal Influenza Vaccines Market Forecast, By Age Group 13.21.1. Pediatric 13.21.2. Adult 13.22. North America Seasonal Influenza Vaccines Market Attractiveness Analysis 13.22.1. By Vaccine type 13.22.2. By Virus 13.22.3. By Distribution 13.22.4. By Age Group 13.22.5. By Distribution Channel 13.23. PEST Analysis 13.24. Key Trends 13.25. Key Developments 14. Europe Seasonal Influenza Vaccines Market Analysis 14.1. Key Findings 14.2. Europe Seasonal Influenza Vaccines Market Overview 14.3. Europe Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 14.4. Europe Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.4.1. Quadrivalent 14.4.2. Trivalent 14.4.3. High-dose 14.5. Europe Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 14.6. Europe Seasonal Influenza Vaccines Market Forecast, By Virus 14.6.1. Type A (H1N1) 14.6.2. Type A (H3N2) 14.6.3. Type B 14.7. Europe Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 14.8. Europe Seasonal Influenza Vaccines Market Forecast, By Distribution 14.8.1. Hospital Pharmacies 14.8.2. Retail Pharmacies 14.8.3. Online Pharmacies 14.9. Europe Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 14.10. Europe Seasonal Influenza Vaccines Market Forecast, By Age Group 14.10.1. Pediatric 14.10.2. Adult 14.11. Europe Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution Channel 14.12. Europe Seasonal Influenza Vaccines Market Value Share Analysis, by Country 14.13. Europe Seasonal Influenza Vaccines Market Forecast, by Country 14.13.1. Germany 14.13.2. U.K. 14.13.3. France 14.13.4. Italy 14.13.5. Spain 14.13.6. Rest of Europe 14.14. Europe Seasonal Influenza Vaccines Market Analysis, by Country 14.15. Germany Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.15.1. Quadrivalent 14.15.2. Trivalent 14.15.3. High-dose 14.16. Germany Seasonal Influenza Vaccines Market Forecast, By Virus 14.16.1. Type A (H1N1) 14.16.2. Type A (H3N2) 14.16.3. Type B 14.17. Germany Seasonal Influenza Vaccines Market Forecast, By Distribution 14.17.1. Hospital Pharmacies 14.17.2. Retail Pharmacies 14.17.3. Online Pharmacies 14.18. Germany Seasonal Influenza Vaccines Market Forecast, By Age Group 14.18.1. Pediatric 14.18.2. Adult 14.19. U.K. Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.19.1. Quadrivalent 14.19.2. Trivalent 14.19.3. High-dose 14.20. U.K. Seasonal Influenza Vaccines Market Forecast, By Virus 14.20.1. Type A (H1N1) 14.20.2. Type A (H3N2) 14.20.3. Type B 14.21. U.K. Seasonal Influenza Vaccines Market Forecast, By Distribution 14.21.1. Hospital Pharmacies 14.21.2. Retail Pharmacies 14.21.3. Online Pharmacies 14.22. U.K. Seasonal Influenza Vaccines Market Forecast, By Age Group 14.22.1. Pediatric 14.22.2. Adult 14.23. France Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.23.1. Quadrivalent 14.23.2. Trivalent 14.23.3. High-dose 14.24. France Seasonal Influenza Vaccines Market Forecast, By Virus 14.24.1. Type A (H1N1) 14.24.2. Type A (H3N2) 14.24.3. Type B 14.25. France Seasonal Influenza Vaccines Market Forecast, By Distribution 14.25.1. Hospital Pharmacies 14.25.2. Retail Pharmacies 14.25.3. Online Pharmacies 14.26. France Seasonal Influenza Vaccines Market Forecast, By Age Group 14.26.1. Pediatric 14.26.2. Adult 14.27. Italy Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.27.1. Quadrivalent 14.27.2. Trivalent 14.27.3. High-dose 14.28. Italy Seasonal Influenza Vaccines Market Forecast, By Virus 14.28.1. Type A (H1N1) 14.28.2. Type A (H3N2) 14.28.3. Type B 14.29. Italy Seasonal Influenza Vaccines Market Forecast, By Distribution 14.29.1. Hospital Pharmacies 14.29.2. Retail Pharmacies 14.29.3. Online Pharmacies 14.30. Italy Seasonal Influenza Vaccines Market Forecast, By Age Group 14.30.1. Pediatric 14.30.2. Adult 14.31. Spain Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.31.1. Quadrivalent 14.31.2. Trivalent 14.31.3. High-dose 14.32. Spain Seasonal Influenza Vaccines Market Forecast, By Virus 14.32.1. Type A (H1N1) 14.32.2. Type A (H3N2) 14.32.3. Type B 14.33. Spain Seasonal Influenza Vaccines Market Forecast, By Distribution 14.33.1. Hospital Pharmacies 14.33.2. Retail Pharmacies 14.33.3. Online Pharmacies 14.34. Spain Seasonal Influenza Vaccines Market Forecast, By Age Group 14.34.1. Pediatric 14.34.2. Adult 14.35. Rest of Europe Seasonal Influenza Vaccines Market Forecast, By Vaccine type 14.35.1. Quadrivalent 14.35.2. Trivalent 14.35.3. High-dose 14.36. Rest of Europe Seasonal Influenza Vaccines Market Forecast, By Virus 14.36.1. Type A (H1N1) 14.36.2. Type A (H3N2) 14.36.3. Type B 14.37. Rest of Europe Seasonal Influenza Vaccines Market Forecast, By Distribution 14.37.1. Hospital Pharmacies 14.37.2. Retail Pharmacies 14.37.3. Online Pharmacies 14.38. Rest Of Europe Seasonal Influenza Vaccines Market Forecast, By Age Group 14.38.1. Pediatric 14.38.2. Adult 14.39. Europe Seasonal Influenza Vaccines Market Attractiveness Analysis 14.39.1. By Vaccine type 14.39.2. By Virus 14.39.3. By Distribution 14.39.4. By Age Group 14.39.5. By Distribution Channel 14.40. PEST Analysis 14.41. Key Trends 14.42. Key Developments 15. Asia Pacific Seasonal Influenza Vaccines Market Analysis 15.1. Key Findings 15.2. Asia Pacific Seasonal Influenza Vaccines Market Overview 15.3. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 15.4. Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.4.1. Quadrivalent 15.4.2. Trivalent 15.4.3. High-dose 15.5. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 15.6. Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Virus 15.6.1. Type A (H1N1) 15.6.2. Type A (H3N2) 15.6.3. Type B 15.7. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 15.8. Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Distribution 15.8.1. Hospital Pharmacies 15.8.2. Retail Pharmacies 15.8.3. Online Pharmacies 15.9. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 15.10. Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Age Group 15.10.1. Pediatric 15.10.2. Adult 15.11. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution Channel 15.12. Asia Pacific Seasonal Influenza Vaccines Market Value Share Analysis, by Country 15.13. Asia Pacific Seasonal Influenza Vaccines Market Forecast, by Country 15.13.1. China 15.13.2. India 15.13.3. Japan 15.13.4. ASEAN 15.13.5. Rest of Asia Pacific 15.14. Asia Pacific Seasonal Influenza Vaccines Market Analysis, by Country 15.15. China Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.15.1. Quadrivalent 15.15.2. Trivalent 15.15.3. High-dose 15.16. China Seasonal Influenza Vaccines Market Forecast, By Virus 15.16.1. Type A (H1N1) 15.16.2. Type A (H3N2) 15.16.3. Type B 15.17. China Seasonal Influenza Vaccines Market Forecast, By Distribution 15.17.1. Hospital Pharmacies 15.17.2. Retail Pharmacies 15.17.3. Online Pharmacies 15.18. China Seasonal Influenza Vaccines Market Forecast, By Age Group 15.18.1. Pediatric 15.18.2. Adult 15.19. India Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.19.1. Quadrivalent 15.19.2. Trivalent 15.19.3. High-dose 15.20. India Seasonal Influenza Vaccines Market Forecast, By Virus 15.20.1. Type A (H1N1) 15.20.2. Type A (H3N2) 15.20.3. Type B 15.21. India Seasonal Influenza Vaccines Market Forecast, By Distribution 15.21.1. Hospital Pharmacies 15.21.2. Retail Pharmacies 15.21.3. Online Pharmacies 15.22. India Seasonal Influenza Vaccines Market Forecast, By Age Group 15.22.1. Pediatric 15.22.2. Adult 15.23. Japan Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.23.1. Quadrivalent 15.23.2. Trivalent 15.23.3. High-dose 15.24. Japan Seasonal Influenza Vaccines Market Forecast, By Virus 15.24.1. Type A (H1N1) 15.24.2. Type A (H3N2) 15.24.3. Type B 15.25. Japan Seasonal Influenza Vaccines Market Forecast, By Distribution 15.25.1. Hospital Pharmacies 15.25.2. Retail Pharmacies 15.25.3. Online Pharmacies 15.26. Japan Seasonal Influenza Vaccines Market Forecast, By Age Group 15.26.1. Pediatric 15.26.2. Adult 15.27. ASEAN Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.27.1. Quadrivalent 15.27.2. Trivalent 15.27.3. High-dose 15.28. ASEAN Seasonal Influenza Vaccines Market Forecast, By Virus 15.28.1. Type A (H1N1) 15.28.2. Type A (H3N2) 15.28.3. Type B 15.29. ASEAN Seasonal Influenza Vaccines Market Forecast, By Distribution 15.29.1. Hospital Pharmacies 15.29.2. Retail Pharmacies 15.29.3. Online Pharmacies 15.30. ASEAN Seasonal Influenza Vaccines Market Forecast, By Age Group 15.30.1. Pediatric 15.30.2. Adult 15.31. Rest of Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Vaccine type 15.31.1. Quadrivalent 15.31.2. Trivalent 15.31.3. High-dose 15.32. Rest of Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Virus 15.32.1. Type A (H1N1) 15.32.2. Type A (H3N2) 15.32.3. Type B 15.33. Rest of Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Distribution 15.33.1. Hospital Pharmacies 15.33.2. Retail Pharmacies 15.33.3. Online Pharmacies 15.34. Rest of Asia Pacific Seasonal Influenza Vaccines Market Forecast, By Age Group 15.34.1. Pediatric 15.34.2. Adult 15.35. Asia Pacific Seasonal Influenza Vaccines Market Attractiveness Analysis 15.35.1. By Vaccine type 15.35.2. By Virus 15.35.3. By Distribution 15.35.4. By Age Group 15.35.5. By Distribution Channel 15.36. PEST Analysis 15.37. Key Trends 15.38. Key Developments 16. Middle East & Africa Seasonal Influenza Vaccines Market Analysis 16.1. Key Findings 16.2. Middle East & Africa Seasonal Influenza Vaccines Market Overview 16.3. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 16.4. Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Vaccine type 16.4.1. Quadrivalent 16.4.2. Trivalent 16.4.3. High-dose 16.5. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 16.6. Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Virus 16.6.1. Type A (H1N1) 16.6.2. Type A (H3N2) 16.6.3. Type B 16.7. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 16.8. Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Distribution 16.8.1. Hospital Pharmacies 16.8.2. Retail Pharmacies 16.8.3. Online Pharmacies 16.9. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 16.10. Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Age Group 16.10.1. Pediatric 16.10.2. Adult 16.11. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution Channel 16.12. Middle East & Africa Seasonal Influenza Vaccines Market Value Share Analysis, by Country 16.13. Middle East & Africa Seasonal Influenza Vaccines Market Forecast, by Country 16.13.1. GCC 16.13.2. South Africa 16.13.3. Rest of Middle East & Africa 16.14. Middle East & Africa Seasonal Influenza Vaccines Market Analysis, by Country 16.15. GCC Seasonal Influenza Vaccines Market Forecast, By Vaccine type 16.15.1. Quadrivalent 16.15.2. Trivalent 16.15.3. High-dose 16.16. Services GCC Seasonal Influenza Vaccines Market Forecast, By Virus 16.16.1. Type A (H1N1) 16.16.2. Type A (H3N2) 16.16.3. Type B 16.17. GCC Seasonal Influenza Vaccines Market Forecast, By Distribution 16.17.1. Hospital Pharmacies 16.17.2. Retail Pharmacies 16.17.3. Online Pharmacies 16.18. GCC Seasonal Influenza Vaccines Market Forecast, By Age Group 16.18.1. Pediatric 16.18.2. Adult 16.19. South Africa Seasonal Influenza Vaccines Market Forecast, By Vaccine type 16.19.1. Quadrivalent 16.19.2. Trivalent 16.19.3. High-dose 16.20. South Africa Seasonal Influenza Vaccines Market Forecast, By Virus 16.20.1. Type A (H1N1) 16.20.2. Type A (H3N2) 16.20.3. Type B 16.21. South Africa Seasonal Influenza Vaccines Market Forecast, By Distribution 16.21.1. Hospital Pharmacies 16.21.2. Retail Pharmacies 16.21.3. Online Pharmacies 16.22. South Africa Seasonal Influenza Vaccines Market Forecast, By Age Group 16.22.1. Pediatric 16.22.2. Adult 16.23. Rest of Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Vaccine type 16.23.1. Quadrivalent 16.23.2. Trivalent 16.23.3. High-dose 16.24. Rest of Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Virus 16.24.1. Type A (H1N1) 16.24.2. Type A (H3N2) 16.24.3. Type B 16.25. Rest of Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Distribution 16.25.1. Hospital Pharmacies 16.25.2. Retail Pharmacies 16.25.3. Online Pharmacies 16.26. Rest of Middle East & Africa Seasonal Influenza Vaccines Market Forecast, By Age Group 16.26.1. Pediatric 16.26.2. Adult 16.27. Middle East & Africa Seasonal Influenza Vaccines Market Attractiveness Analysis 16.27.1. By Vaccine type 16.27.2. By Virus 16.27.3. By Distribution 16.27.4. By Age Group 16.27.5. By Distribution Channel 16.28. PEST Analysis 16.29. Key Trends 16.30. Key Developments 17. South America Seasonal Influenza Vaccines Market Analysis 17.1. Key Findings 17.2. South America Seasonal Influenza Vaccines Market Overview 17.3. South America Seasonal Influenza Vaccines Market Value Share Analysis, By Vaccine type 17.4. South America Seasonal Influenza Vaccines Market Forecast, By Vaccine type 17.4.1. Quadrivalent 17.4.2. Trivalent 17.4.3. High-dose 17.5. South America Seasonal Influenza Vaccines Market Value Share Analysis, By Virus 17.6. South America Seasonal Influenza Vaccines Market Forecast, By Virus 17.6.1. Type A (H1N1) 17.6.2. Type A (H3N2) 17.6.3. Type B 17.7. South America Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution 17.8. South America Seasonal Influenza Vaccines Market Forecast, By Distribution 17.8.1. Hospital Pharmacies 17.8.2. Retail Pharmacies 17.8.3. Online Pharmacies 17.9. South America Seasonal Influenza Vaccines Market Value Share Analysis, By Age Group 17.10. South America Seasonal Influenza Vaccines Market Forecast, By Age Group 17.10.1. Pediatric 17.10.2. Adult 17.11. South America Seasonal Influenza Vaccines Market Value Share Analysis, By Distribution Channel 17.12. South America Seasonal Influenza Vaccines Market Value Share Analysis, by Country 17.13. South America Seasonal Influenza Vaccines Market Forecast, by Country 17.13.1. Brazil 17.13.2. Mexico 17.13.3. Rest of South America 17.14. South America Seasonal Influenza Vaccines Market Analysis, by Country 17.15. Brazil Seasonal Influenza Vaccines Market Forecast, By Vaccine type 17.15.1. Quadrivalent 17.15.2. Trivalent 17.15.3. High-dose 17.16. Brazil Seasonal Influenza Vaccines Market Forecast, By Virus 17.16.1. Type A (H1N1) 17.16.2. Type A (H3N2) 17.16.3. Type B 17.17. Brazil Seasonal Influenza Vaccines Market Forecast, By Distribution 17.17.1. Hospital Pharmacies 17.17.2. Retail Pharmacies 17.17.3. Online Pharmacies 17.18. Brazil Seasonal Influenza Vaccines Market Forecast, By Age Group 17.18.1. Pediatric 17.18.2. Adult 17.19. Mexico Seasonal Influenza Vaccines Market Forecast, By Vaccine type 17.19.1. Quadrivalent 17.19.2. Trivalent 17.19.3. High-dose 17.20. Mexico Seasonal Influenza Vaccines Market Forecast, By Virus 17.20.1. Type A (H1N1) 17.20.2. Type A (H3N2) 17.20.3. Type B 17.21. Mexico Seasonal Influenza Vaccines Market Forecast, By Distribution 17.21.1. Hospital Pharmacies 17.21.2. Retail Pharmacies 17.21.3. Online Pharmacies 17.22. Mexico Seasonal Influenza Vaccines Market Forecast, By Age Group 17.22.1. Pediatric 17.22.2. Adult 17.23. Rest of South America Seasonal Influenza Vaccines Market Forecast, By Vaccine type 17.23.1. Quadrivalent 17.23.2. Trivalent 17.23.3. High-dose 17.24. Rest of South America Seasonal Influenza Vaccines Market Forecast, By Virus 17.24.1. Brass 17.24.2. Stainless Steel 17.25. Rest of South America Seasonal Influenza Vaccines Market Forecast, By Distribution 17.25.1. Hospital Pharmacies 17.25.2. Retail Pharmacies 17.25.3. Online Pharmacies 17.26. Rest of South America Seasonal Influenza Vaccines Market Forecast, By Age Group 17.26.1. Pediatric 17.26.2. Adult 17.27. Rest of South America Seasonal Influenza Vaccines Market Forecast, By Distribution Channel 17.27.1. Oil & Gas 17.27.2. Chemical 17.27.3. Steel and Metal Processing 17.27.4. Pharmaceuticals 17.27.5. Other Application 17.28. South America Seasonal Influenza Vaccines Market Attractiveness Analysis 17.28.1. By Vaccine type 17.28.2. By Virus 17.28.3. By Distribution 17.28.4. By Age Group 17.28.5. By Distribution Channel 17.29. PEST Analysis 17.30. Key Trends 17.31. Key Developments 18. Company Profiles 18.1. Market Share Analysis, by Company 18.2. Competition Matrix 18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 18.2.2. New Product Launches and Product Enhancements 18.2.3. Market Consolidation 18.2.3.1. M&A by Regions, Investment and Applications 18.2.3.2. M&A Key Players, Forward Integration and Backward Integration 18.3. Company Profiles: Key Players 18.3.1. Sinovac Biotech 18.3.1.1. Company Overview 18.3.1.2. Financial Overview 18.3.1.3. Product Portfolio 18.3.1.4. Business Strategy 18.3.1.5. Recent Developments 18.3.1.6. Development Footprint 18.3.2. laxoSmithKline 18.3.3. Novartis 18.3.4. CSL 18.3.5. MedImmune 18.3.6. Sanofi-Pasteur 18.3.7. Solvay 18.3.8. Sinovac Biotech 18.3.9. Hualun Biologicals. 18.3.10. Pernix Therapeutics 18.3.11. Pfizer Inc 18.3.12. Purdue Pharma L.P. 18.3.13. Sanofi Pasteur 18.3.14. SkyePharma 18.3.15. GlaxoSmithKline Plc. 18.3.16. AstraZenca 18.3.17. Abbott Laboratories 18.3.18. Seqirus 18.3.19. Mitsubishi Tanabe Pharma 18.3.20. Serum Institute of India Pvt. Ltd 18.3.21. Mylan NV 19. Primary Key Insights